ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2020
Strong sales growth during August: Zinzino group revenue increased with a total of 45%, compared with the previous year.
The revenue in August for Zinzino's sales markets increased by 50% to MSEK 82.0 (54.7) primarily due to strong growth foremost in Central Europe. Faun Pharma's external sales decreased by 19% and amounted to MSEK 3.4 (4.2). Overall, the Group increased revenues by 45% to MSEK 85.4 (58.9) compared with the previous year.
Accumulated revenue for January – August 2020 increased by 47% MSEK 690.9 (469.7).
Revenues distributed as follows:
|Regions,MSEK||20-aug||19-aug||Change||YTD 2020||YTD 2019||Change|
|Europe Other Markets||42,0||19.6||114%||321.5||140.3||129%|
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, email@example.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: firstname.lastname@example.org
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 11:15 the 7th of September 2020.
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, Florida and Adelaide. Zinzino is a public company and its shares are listed on Nasdaq First North Growth Market.